← Back to headlines
J&J's Rybrevant Faspro Receives Monthly Dosing Approval
Johnson & Johnson has secured approval for monthly dosing of its drug Rybrevant Faspro, offering a new treatment option.
17 Feb, 14:18 — 17 Feb, 14:18
ℹOnly 1 source covers this story
